佰仁医疗(688198)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688198 佰仁医疗

已收盘 05-17 15:00:00

{"stockData":{"symbol":"688198","market":"SH","secType":"STK","nameCN":"佰仁医疗","latestPrice":109.78,"timestamp":1715929200000,"preClose":107.94,"halted":0,"volume":253215,"delay":0,"floatShares":137000000,"shares":137000000,"eps":0.8188,"marketStatus":"已收盘","marketStatusCode":5,"change":1.84,"latestTime":"05-17 15:00:00","open":107.33,"high":110.66,"low":107,"amount":27571200,"amplitude":0.0339,"askPrice":109.94,"askSize":5,"bidPrice":109.78,"bidSize":7,"shortable":0,"etf":0,"ttmEps":0.8188,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716168600000},"adr":0,"adjPreClose":107.94,"symbolType":"stock_kcb","openAndCloseTimeList":[[1715909400000,1715916600000],[1715922000000,1715929200000]],"highLimit":118.73,"lowLimit":97.15,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":136579240,"pbRate":12.42,"roa":"--","roe":"0.69%","epsLYR":0.85,"committee":-0.627907,"marketValue":14994000000,"floatMarketCap":14994000000,"peRate":134.07426,"changeRate":0.017,"turnoverRate":0.0019,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-05-20。","afterMarket":{"amount":0,"volume":0,"close":109.78,"buyVolume":0,"sellVolume":0,"time":1715931239505,"indexStatus":"已收盘 05-17 15:30:00","preClose":107.94}},"requestUrl":"/m/hq/s/688198","defaultTab":"news","newsList":[{"id":"2436938962","title":"佰仁医疗05月17日获主力加仓248万元 环比增加853.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436938962","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2436938962?lang=zh_cn&edition=full","pubTime":"2024-05-17 15:19","pubTimestamp":1715930343,"startTime":"0","endTime":"0","summary":"05月17日, 佰仁医疗股价涨1.70%，报收109.78元，成交金额2757万元，换手率0.19%，振幅3.39%，量比1.18。佰仁医疗今日主力资金净流入248万元，连续3日净流入，上一交易日主力净流入26万元，今日环比增加853.85%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为31.58%，平均涨幅为1.52%。该股近5个交易日下跌4.68%，主力资金累计净流入361万元；近20日主力资金累计净流出449万元，其中净流出天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051715330087737481&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051715330087737481&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434815697","title":"佰仁医疗（688198）5月10日主力资金净卖出1109.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434815697","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434815697?lang=zh_cn&edition=full","pubTime":"2024-05-11 07:55","pubTimestamp":1715385346,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月10日收盘，佰仁医疗报收于115.17元，下跌3.33%，换手率0.26%，成交量3491.0手，成交额4067.12万元。近5日资金流向一览见下表：佰仁医疗融资融券信息显示，融资方面，当日融资买入256.22万元，融资偿还135.88万元，融资净买入120.34万元，连续3日净买入累计307.26万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051100012634.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433752389","title":"佰仁医疗（688198）5月7日主力资金净买入18.70万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433752389","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433752389?lang=zh_cn&edition=full","pubTime":"2024-05-08 07:51","pubTimestamp":1715125862,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月7日收盘，佰仁医疗报收于118.66元，下跌2.06%，换手率0.17%，成交量2389.0手，成交额2854.73万元。近5日资金流向一览见下表：佰仁医疗融资融券信息显示，融资方面，当日融资买入169.35万元，融资偿还156.41万元，融资净买入12.95万元，连续3日净买入累计393.03万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800009554.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433141624","title":"佰仁医疗上涨5.08%创近1月新高 高精尖技术产品首发会","url":"https://stock-news.laohu8.com/highlight/detail?id=2433141624","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2433141624?lang=zh_cn&edition=full","pubTime":"2024-05-06 14:39","pubTimestamp":1714977544,"startTime":"0","endTime":"0","summary":"05月06日，佰仁医疗股价大幅上涨，截至14点39分，佰仁医疗上涨5.08%，报124.23元/股，创近1月新高，成交3029万元，换手率0.18%，振幅4.42%。北向资金方面，佰仁医疗04月30日获得北向资金减持1.10万股，截至04月30日，北向资金当前共持有佰仁医疗29.52万股，市值3667万元，持股占流通股比为0.21%。最新财报显示，今年一季报，佰仁医疗实现营业收入7,626.52万元，同比增长17.53%，净利润为831.98万元，同比减少28.88%，基本每股收益为0.06元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405061440417925f355&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405061440417925f355&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431019078","title":"佰仁医疗获中银证券买入评级，业绩稳定增长，新产品引领成长新动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2431019078","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431019078?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:03","pubTimestamp":1714439004,"startTime":"0","endTime":"0","summary":"4月30日，佰仁医疗获中银证券买入评级，近一个月佰仁医疗获得3份研报关注。中银证券指出，2023年佰仁医疗业绩稳定增长，营业收入达3.71亿元，同比增长25.57%，归母净利润为1.15亿元，同比增长21.11%。中银证券预计2024年至2026年，佰仁医疗的归母净利润分别为1.65亿元、2.30亿元、3.26亿元。风险提示方面，中银证券提到产品研发失败风险、产品销售不及预期风险，以及带量采购政策变动风险等可能对公司评级产生影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300915448b641c36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300915448b641c36&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431004181","title":"佰仁医疗04月29日遭主力抛售150万元 环比增加275.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431004181","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431004181?lang=zh_cn&edition=full","pubTime":"2024-04-29 15:19","pubTimestamp":1714375159,"startTime":"0","endTime":"0","summary":"04月29日, 佰仁医疗股价涨4.30%，报收118.55元，成交金额3515万元，换手率0.22%，振幅5.12%，量比1.18。佰仁医疗今日主力资金净流出150万元，连续5日净流出，上一交易日主力净流出40万元，今日环比增加275.00%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为20.00%，平均跌幅为0.46%。该股近5个交易日上涨6.59%，主力资金累计净流出504万元；近20日主力资金累计净流入500万元，其中净流入天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042915365987be0089&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042915365987be0089&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431032070","title":"佰仁医疗(688198)2023年年报&2024年一季报点评：业绩增长韧性强，在研管线持续获证中","url":"https://stock-news.laohu8.com/highlight/detail?id=2431032070","media":"东方证券","top":-1,"share":"https://www.laohu8.com/m/news/2431032070?lang=zh_cn&edition=full","pubTime":"2024-04-29 14:17","pubTimestamp":1714371450,"startTime":"0","endTime":"0","summary":"牛心包瓣持续放量，择期手术有望不断恢复。根据2023年年报及2024年一季报，目前行业手术量尚处于恢复阶段，因此我们下调心脏瓣膜置换与修复治疗、补片类产品收入；同时公司近年来持续重视产品研发，新品正逐步上市，产品推广需求增加，因此我们上调期间费用率。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042914313287bdc0b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042914313287bdc0b8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430158421","title":"佰仁医疗04月25日主力资金流出62万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2430158421","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430158421?lang=zh_cn&edition=full","pubTime":"2024-04-25 15:18","pubTimestamp":1714029498,"startTime":"0","endTime":"0","summary":"04月25日, 佰仁医疗股价跌1.88%，报收109.63元，成交金额1684万元，换手率0.11%，振幅3.33%，量比0.57。佰仁医疗今日主力资金净流出62万元，连续3日净流出，上一交易日主力净流出204万元，今日环比减少69.61%。该股近5个交易日上涨4.91%，主力资金累计净流入181万元；近20日主力资金累计净流入1025万元，其中净流入天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042515272787ae065b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042515272787ae065b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429485397","title":"佰仁医疗04月24日遭主力抛售204万元 环比增加300.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429485397","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429485397?lang=zh_cn&edition=full","pubTime":"2024-04-24 15:19","pubTimestamp":1713943183,"startTime":"0","endTime":"0","summary":"04月24日, 佰仁医疗股价涨4.05%，报收111.73元，成交金额3221万元，换手率0.21%，振幅6.25%，量比1.13。佰仁医疗今日主力资金净流出204万元，上一交易日主力净流出51万元，今日环比增加300.00%。该股近5个交易日上涨4.95%，主力资金累计净流出52万元；近20日主力资金累计净流入1158万元，其中净流入天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404241536418b4dddc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404241536418b4dddc1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429623125","title":"佰仁医疗（688198）2024年一季报简析：增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2429623125","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429623125?lang=zh_cn&edition=full","pubTime":"2024-04-24 06:11","pubTimestamp":1713910289,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期佰仁医疗发布2024年一季报。根据财报显示，本报告期中佰仁医疗增收不增利。截至本报告期末，公司营业总收入7626.52万元，同比上升17.53%，归母净利润831.98万元，同比下降28.88%。负债状况方面，公司报告期内合同负债规模环比增幅达252.98%，未完成订单增加，可能的原因有公司交货变慢或者下游需求增强。注意公司报告期内应付账款的构成。营收分析方面，公司最新一期年度报表的现金流为正，经营性现金流和利润相匹配。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400011877.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429813823","title":"佰仁医疗大跌5.14% 一季报净利润同比下降28.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429813823","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2429813823?lang=zh_cn&edition=full","pubTime":"2024-04-23 09:54","pubTimestamp":1713837247,"startTime":"0","endTime":"0","summary":"04月23日，佰仁医疗股价大幅下跌，截至09点54分，佰仁医疗下跌5.14%，报105.50元/股，成交1094万元，换手率0.07%，振幅3.80%。消息解读2024年4月23日，佰仁医疗披露2024年一季报。北向资金方面，佰仁医疗04月22日获得北向资金增持0.70万股，截至04月22日，北向资金当前共持有佰仁医疗30.68万股，市值3236万元，持股占流通股比为0.22%。最新财报显示，今年一季报，佰仁医疗实现营业收入7,626.52万元，同比增长17.53%，净利润为831.98万元，同比减少28.88%，基本每股收益为0.06元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231028477a54b951&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231028477a54b951&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429243924","title":"佰仁医疗去年研发费用9881.25万元 同比增长79.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429243924","media":"新京报","top":-1,"share":"https://www.laohu8.com/m/news/2429243924?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:49","pubTimestamp":1713793789,"startTime":"0","endTime":"0","summary":"2023年，佰仁医疗研发费用为9881.25万元，同比增长79.18%，主要是人员薪酬福利费用及临床试验检测费用增加所致，剔除股份支付影响，研发费用同比增长101.60%。同日，佰仁医疗发布2024年第一季度报告，第一季度实现营业收入7626.52万元，同比增长17.53%；净利润为831.98万元，同比下降28.88%，剔除股份支付影响后实现归属于上市公司股东的净利润1344.45万元，同比下降39.55%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222151268b465d23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222151268b465d23&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429092341","title":"佰仁医疗2023年净利1.15亿同比增长21.11% 董事长金磊薪酬72万","url":"https://stock-news.laohu8.com/highlight/detail?id=2429092341","media":"挖贝网","top":-1,"share":"https://www.laohu8.com/m/news/2429092341?lang=zh_cn&edition=full","pubTime":"2024-04-22 20:36","pubTimestamp":1713789407,"startTime":"0","endTime":"0","summary":"挖贝网4月22日，佰仁医疗 近日发布2023年年度报告，报告期内公司实现营业收入370,638,328.12元，同比增长25.57%；归属于上市公司股东的净利润115,206,553.74元，同比增长21.11%。报告期内经营活动产生的现金流量净额为141,165,115.94元，归属于上市公司股东的净资产1,194,613,168.74元。公司报告期实现归属于上市公司股东的净利润11,520.66万元，同比增长21.11%。公告显示，报告期内董事、监事、高级管理人员报酬合计687.41万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042220382087a16e0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042220382087a16e0e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429923635","title":"中银证券：给予佰仁医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429923635","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429923635?lang=zh_cn&edition=full","pubTime":"2024-04-22 20:30","pubTimestamp":1713789058,"startTime":"0","endTime":"0","summary":"中银国际证券股份有限公司刘恩阳,薛源近期对佰仁医疗进行研究并发布了研究报告《佰仁医疗血管生物补片获批，拓宽未来增量空间》，本报告对佰仁医疗给出买入评级，当前股价为111.22元。最新盈利预测明细如下：该股最近90天内共有1家机构给出评级，买入评级1家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200026919.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429912400","title":"图解佰仁医疗一季报：第一季度单季净利润同比减28.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429912400","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429912400?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:42","pubTimestamp":1713775361,"startTime":"0","endTime":"0","summary":"证券之星消息，佰仁医疗2024年一季报显示，公司主营收入7626.52万元，同比上升17.53%；归母净利润831.98万元，同比下降28.88%；扣非净利润637.78万元，同比下降29.26%；负债率8.6%，投资收益280.39万元，财务费用-423.02万元，毛利率89.28%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200017307.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429914582","title":"佰仁医疗将于5月13日召开股东大会，审议公司2023年度利润分配方案等议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2429914582","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2429914582?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:16","pubTimestamp":1713773805,"startTime":"0","endTime":"0","summary":"金融界4月22日消息，佰仁医疗发布公告，将于2024年5月13日召开年度股东大会，网络投票同日进行。股权登记日为5月6日，当日收市后持有佰仁医疗股票的投资者可以参与投票。会议地点：北京市昌平区科技园东区华昌路2号公司会议室。本次股东大会共计审计9项议案，具体如下：1、《关于的议案》2、《关于的议案》3、《关于的议案》4、《关于的议案》5、《关于公司2023年度利润分配方案的议案》6、《关于及其摘要的议案》7、《关于公司董事2024年度薪酬(津贴)方案的议案》8、《关于公司监事2024年度薪酬方案的议案》9、《关于续聘致同会计师事务所(特殊普通合伙)为公司2024年度审计机构的议案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221623538b454244&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221623538b454244&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429391455","title":"佰仁医疗：2024年第一季度净利润约832万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429391455","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2429391455?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:05","pubTimestamp":1713773126,"startTime":"0","endTime":"0","summary":"佰仁医疗（SH 688198，收盘价：111.22元）4月22日晚间发布一季度业绩公告称，2024年第一季度营收约7627万元，同比增加17.53%；归属于上市公司股东的净利润约832万元，同比减少28.88%；基本每股收益0.06元，同比减少33.33%。佰仁医疗的总经理、董事长均是金磊，男，70岁，学历背景为博士。截至发稿，佰仁医疗市值为152亿元。文章来源：每日经济新闻原标题：佰仁医疗：2024年第一季度净利润约832万元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042216192587a07304&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042216192587a07304&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-12-09","address":"北京市昌平区科技园东区华昌路2号","stockEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":0.0312},{"period":"3month","weight":-0.1443},{"period":"6month","weight":-0.2248},{"period":"1year","weight":0.0288},{"period":"ytd","weight":-0.1184}],"companyName":"北京佰仁医疗科技股份有限公司","boardCode":"AI0035","perCapita":"50962股","boardName":"专用设备制造业","registeredCapital":"13657万元","compareEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.0326},{"period":"1year","weight":-0.0435},{"period":"ytd","weight":0.0602}],"survey":"　　北京佰仁医疗科技股份有限公司是国内技术领先的、专注于动物源性植介入医疗器械研发与生产的高新技术企业,主要产品主要包括心脏瓣膜置换与修复、先天性心脏病植介入治疗、外科软组织修复等。","serverTime":1716110778231,"listedPrice":23.68,"stockholders":"2680人(较上一季度增加2.29%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"佰仁医疗(688198)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供佰仁医疗(688198)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"佰仁医疗,688198,佰仁医疗股票,佰仁医疗股票老虎,佰仁医疗股票老虎国际,佰仁医疗行情,佰仁医疗股票行情,佰仁医疗股价,佰仁医疗股市,佰仁医疗股票价格,佰仁医疗股票交易,佰仁医疗股票购买,佰仁医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"佰仁医疗(688198)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供佰仁医疗(688198)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}